Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
September 30 2022 - 9:31AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
FORM 6-K
REPORT OF FOREIGN PRIVATE
ISSUER
Pursuant
to Rule 13a-16 or 15d-16 of the
Securities
Exchange Act of 1934
For
the month of September 2022
Commission
file number: 001-32749
FRESENIUS
MEDICAL CARE AG & Co. KGaA
(Translation
of registrant's name into English)
Else-Kröner
Strasse 1
61346
Bad Homburg
Germany
(Address
of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F
¨
Indicate by check mark if
the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if
the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
On September 26, 2022, Mr.
Michael Sen, 53, was elected to the supervisory board of Fresenius Medical Care Management AG, the general partner of Fresenius Medical
Care AG & Co. KGaA. He was also elected Chairman of the general partner’s supervisory board, effective in both cases October
1, 2022, succeeding Stephan Sturm. Fresenius SE previously announced that Mr. Sen will become Chief Executive Officer of Fresenius SE
on October 1, 2022, to succeed Stephan Sturm. Mr. Sen joined the Management Board of Fresenius Management SE in April 2021 with responsibility
for Fresenius Kabi AG, a wholly-owned subsidiary of Fresenius SE specializing in lifesaving medicines and technologies for infusion, transfusion
and clinical nutrition. Mr. Sen will continue to serve as CEO of Fresenius Kabi until a successor is decided for this position. Before
joining Fresenius Kabi, he was a member of the Management Board of Siemens AG, where he was responsible for the healthcare business Siemens
Healthineers and for Siemens’ energy business. Prior to that, he was Chief Financial Officer of E.ON SE. At the start of his professional
career, Mr. Sen completed an apprenticeship at Siemens in Berlin and then studied business administration at the Technical University
of Berlin.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
DATE: September 30, 2022
|
Fresenius
Medical Care AG & Co. KGaA, |
|
a partnership limited by
shares, represented by: |
|
|
|
fresenius
medical care management ag, its General Partner |
|
|
|
By: |
/s/ Rice
Powell |
|
|
Name: |
Rice Powell |
|
|
Title: |
Chief Executive Officer and Chairman of the Management Board of the General Partner |
|
|
|
|
|
By: |
/s/ Helen
Giza |
|
|
Name: |
Helen Giza |
|
|
Title: |
Deputy Chief Executive Officer, Chief Financial Officer and Member of the Management Board of the General
Partner |
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Jul 2023 to Jul 2024